MARKET

TLSIW

TLSIW

TriSalus Life Sciences Inc.
NASDAQ
0.6681
-0.0519
-7.21%
Opening 10:03 05/29 EDT
OPEN
0.6681
PREV CLOSE
0.7200
HIGH
0.6681
LOW
0.6130
VOLUME
476
TURNOVER
--
52 WEEK HIGH
5.000
52 WEEK LOW
0.4405
MARKET CAP
--
P/E (TTM)
-0.4738
1D
5D
1M
3M
1Y
5Y
1D
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks · 3h ago
Weekly Report: what happened at TLSI last week (0518-0522)?
Weekly Report · 4d ago
Securities Fraud Investigation Into TriSalus Life Sciences Inc. (TLSI) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
Barchart · 05/20 11:00
TLSI Investor Alert: Levi & Korsinsky Investigates TLSI (TLSI) for Potential Securities Fraud
Barchart · 05/19 15:00
Securities Fraud Investigation Into TriSalus Life Sciences Inc. (TLSI) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
Barchart · 05/19 14:47
Analysts’ Top Healthcare Picks: Compugen (CGEN), TriSalus Life Sciences (TLSI)
TipRanks · 05/19 13:30
TriSalus Leaders Quietly Make a Bold Bet on the Company’s Future
TipRanks · 05/19 02:16
TriSalus director Mats Wahlstrom buys 60,000 shares worth $151,800
PUBT · 05/18 20:43
More
About TLSIW
TriSalus Life Sciences, Inc. is an oncology-focused medical technology company. It is seeking to transform outcomes for patients with solid tumors by integrating its delivery technology with standard-of-care therapies, and with its investigational immunotherapeutic, nelitolimod, a class C Toll-like receptor 9 agonist, for a range of different therapeutic and technological applications. Its delivery method, Pressure-Enabled Drug Delivery (PEDD), modulates pressure and flow within blood vessels to improve intravascular therapeutic delivery into tumors, thereby increasing the likelihood of tumor response in comparison to conventional delivery technologies. Its on-market TriNav Infusion System using PEDD technology, is being used for interventional radiology procedures, commonly transarterial radioembolization (TARE) and transarterial chemoembolization (TACE) in patients with primary liver cancer or in patients with liver metastases. TriNav is a device with a novel (PEDD) delivery method.

Webull offers TriSalus Life Sciences Inc stock information, including NASDAQ: TLSIW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TLSIW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TLSIW stock methods without spending real money on the virtual paper trading platform.